10x Genomics (TXG) Reports Q4 Loss of $16.3M, Revenue $166M

10x Genomics Inc. (TXG) reported a fourth-quarter loss of $16.3 million, or 13 cents per share, on Thursday. Revenue for the quarter totaled $166 million, outperforming the average Zacks estimate of 19 cents per share. For the year, the company recorded a loss of $43.5 million, or 35 cents per share, with annual revenue reaching $642.8 million.